Zhongke Yuanyi Debuts at the 25th China Hi-Tech Fair with Innovative Digital Therapeutics Solutions for Cardiovascular Health
The global health and wellness industry is entering the era of digital medicine. Statistics show that the global digital health market reached $210 billion in 2022, with an projected annual growth rate of up to 18% in the coming years. Currently, China’s exploration of digitalization in the healthcare sector has entered a “deep-water zone.” From AI-assisted clinical diagnosis and innovative drug development to smart hospitals, remote VR surgeries, remote patient monitoring, and wearable health devices, the integration of digital technologies into medical scenarios is advancing toward greater intelligence and precision. How will the rapid iteration of next-generation information technologies, such as artificial intelligence, reshape the form and landscape of digital medicine? Stay tuned for the 25th China Hi-Tech Fair (CHTF).Digital Health Exhibition,Stay ahead in exploring new applications and opportunities in digital health technology.
Zhongke Yuanyi will make a spectacular appearance at the Digital Health Exhibition with its business team and innovative products. We sincerely invite all new and old friends to join us at this grand event! (Booth No.: 2B01)
Image source: WeChat Official Account of the Digital Healthcare Exhibition at China Hi-Tech Fair
The China Hi-Tech Fair (CHTF) is jointly organized by the Ministry of Commerce, the Ministry of Science and Technology, the Ministry of Industry and Information Technology, the National Development and Reform Commission, the Ministry of Agriculture and Rural Affairs, the China National Intellectual Property Administration, the Chinese Academy of Sciences, the Chinese Academy of Engineering, and other ministerial-level departments, together with the Shenzhen Municipal People’s Government. To date, it has been successfully held in Shenzhen for 24 consecutive sessions. As the largest, most effective, and most influential brand exhibition in China’s high-tech sector, it is hailed as “China’s No. 1 Tech Exhibition.”The 25th China Hi-Tech Fair (CHTF2023) will be held inNovember 15–19, 2023Grandly held at the Shenzhen Convention and Exhibition Center.
2023 CHTF Digital Healthcare ExhibitionExpected to attract 350+ exhibitors and 10,000+ professional visitors from around the world, the event will focus on three key areas: AI in healthcare, chronic disease management, and smart elderly care. It will showcase upstream and downstream products, including digital medical equipment, rehabilitation/TCM/dental/ophthalmic devices, medical software, medical robots, medical imaging equipment, pharmaceuticals, medical big data services, genetics, biochemistry, genetic engineering, home healthcare, and wearables. By integrating application scenarios with ecosystem displays, the event aims to promote collaborative innovation among industry, academia, and research institutions.
The exhibition features six application scenario-driven solution zones: Digital Healthcare, Chronic Disease Management, Smart Health and Elderly Care, a Special Exhibition on Computational Imaging/AI in Healthcare, Intelligent Rehabilitation for Cardiovascular and Cerebrovascular Diseases/Diabetes/COPD/Oncology, and Smart Elderly Care/Smart Rehabilitation. It also includes three enterprise pavilions: Medical Device Companies, Pharmaceutical Companies, and Biotechnology Companies. The organizer will continue to optimize the layout of solution and enterprise zones, intensify efforts to invite professional visitors, and consistently enhance the sense of gain for exhibitors and attendees.
Zhongke Yuanyi Booth 2B01
As a company providing medical wearable product solutions centered on 4G-enabled blood pressure and ECG smartwatches, tailored to the 4P management needs of cardiovascular health in digital therapeutics,Zhongke YuanyiParticipated in the Digital Healthcare Exhibition Zone and set up a booth at this year's China Hi-Tech Fair(Booth No.: 2B01), welcome all distinguished guests to our booth!
Business:Zhongke Yuanyi addresses the 4P management needs of digital therapeutics for cardiovascular health by providing a medical wearable product solution centered on its 4G blood pressure and ECG medical smartwatch. Through accurate, continuous, and multi-dimensional data collection and algorithmic analysis of blood pressure and health metrics, it performs attribution analysis for hypertension, enabling more precise interventions and effectively addressing the low rate of hypertension control.
Team:We have a professional team whose core members possess over 10 years of experience in the interdisciplinary field of cardiovascular medical research and medical wearable product development. Our core team members hold postdoctoral fellowships from the University of Nebraska Medical Center (UNMC), Ph.D. degrees from Tsinghua University, and have professional backgrounds at leading domestic and international organizations such as ZTE Corporation.
Collaboration:The Company has established a strategic partnership with the Chinese Academy of Sciences in Xiamen and Germany’s MicroGiant GmbH to conduct clinical studies on continuous blood pressure monitoring, and has obtained German clinical certification under ISO 81060-3. Focusing on the specialized niche of medical wearables, the Company adheres to a strategy of developing highly specialized, refined, distinctive, and innovative capabilities, delivering more professional and efficient cardiovascular health improvement solutions to its customers.
